0001415889-24-018417.txt : 20240628
0001415889-24-018417.hdr.sgml : 20240628
20240628162652
ACCESSION NUMBER: 0001415889-24-018417
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240627
FILED AS OF DATE: 20240628
DATE AS OF CHANGE: 20240628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PETERS WILLIAM J
CENTRAL INDEX KEY: 0001263136
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 241086107
MAIL ADDRESS:
STREET 1: C/O AMPHASTAR PHARMACEUTICALS, INC.
STREET 2: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
form4-06282024_080649.xml
X0508
4
2024-06-27
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001263136
PETERS WILLIAM J
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
true
true
false
false
CFO, EVP & TREASURER
1
Common Stock
2024-06-27
4
S
0
2961
40.8467
D
94738
D
Common Stock
2024-06-27
4
S
0
635
41.2946
D
94103
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.20 to $41.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.
Includes 431 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.22 to $41.36, inclusive.
/s/ William J. Peters
2024-06-28